Objective: To review the literature about the use of atypical antipsychotics in the treatment of pathological aggression in children and adolescents. Method: The databases MEDLINE, SciELO, and LILACS were searched for publications in Portuguese or English from 1992 to August 2011 using the following keywords: mental disease, child, adolescent, treatment, atypical antipsychotic, aggressive behavior, aggression, and violent behavior. Results: Sixty-seven studies of good methodological quality and clinical interest and relevance were identified. Studies including children and adolescents were relatively limited, because few atypical antipsychotics have been approved by the Food and Drug Administration (FDA). All the medications included in this review (risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole and clozapine) have some effectiveness in treating aggression in children and adolescents, and choices should be based on clinical indications and side effects. Conclusions: There are few studies about the effectiveness and safety of atypical antipsychotics for the pediatric population, and further randomized controlled studies with larger groups of patients and more diagnostic categories, such as severe conduct disorder and oppositional defant disorder, should be conducted to confirm the results reported up to date and to evaluate the impact of long-term use. © APRS.353151159Schur, S.B., Sikich, L., Findling, R.L., Malone, R.P., Crismon, M.L., Derivan, A., Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: A review (2003) J Am Acad Child Adolesc Psychiatry, 42, pp. 132-144Prado-Lima, P.A., Pharmacological treatment of impulsivity and aggressive behavior (2009) Rev Bras Psiquiatr, 31 (SUPPL. 2), pp. S58-S65Garland, A.F., Hough, R.L., McCabe, K.M., Yeh, M., Wood, P.A., Aarons, G.A., Prevalence of psychiatric disorders in youths across fve sectors of care (2001) J Am Acad Child Adolesc Psychiatry, 40, pp. 409-418Jensen, P.S., Youngstrom, E.A., Steiner, H., Findling, R.L., Meyer, R.E., Malone, R.P., Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: Implications for medication studies (2007) J Am Acad Child Adolesc Psychiatry, 46, pp. 309-322Siever, L.J., Neurobiology of aggression and violence (2008) Am J Psychiatry, 165, pp. 429-442Siegel, A., Bhatt, S., Bhatt, R., Zalcman, S.S., The neurobiological bases for development of pharmacological treatments of aggressive disorders (2007) Curr Neuropharmacol, 5, pp. 135-147Bordin, I.A., Offord, D.R., Transtorno de conduta e comportamento anti-social (2000) Rev Bras Psiquiatr, 22 (SUPLL. 2), pp. 12-15Mendes, D.D., de Mari, J., Singer, M., Barros, G.M., Mello, A.F., Study review of biological, social and environmental factors associated with aggressive behavior (2009) Rev Bras Psiquiatr, 31 (SUPPL. 2), pp. S77-S85Nestor, P.G., Neuropsychological and clinical correlates of murder and other forms of extreme violence in a forensic psychiatric population (1992) J Nerv Ment Dis, 180, pp. 418-423Bernstein, D.P., Cohen, P., Skodol, A., Bezirganian, S., Brook, J.S., Childhood antecedents of adolescent personality disorders (1996) Am J Psychiatry, 153, pp. 907-913Blair, R.J., Peschardt, K.S., Budhani, S., Mitchell, D.G., Pine, D.S., The development of psychopathy (2006) J Child Psychol Psychiatry, 47, pp. 262-276Soller, M.V., Karnik, N.S., Steiner, H., Psychopharmacologic treatment in juvenile offenders (2006) Child Adolesc Psychiatr Clin N Am, 15, pp. 477-499Pappadopulos, E., Macintyre, I.J.C., Crismon, M.L., Findling, R.L., Malone, R.P., Derivan, A., Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II (2003) J Am Acad Child Adolesc Psychiatry, 42, pp. 145-161James, A.C., Prescribing antipsychotics for children and adolescents (2010) Adv Psychiatr Treat, 16, pp. 63-75Cohen, S.A., Underwood, M.T., The use of clozapine in a mentally retarded and aggressive population (1994) J Clin Psychiatry, 55, pp. 440-444Jensen, P.S., The role of psychosocial therapies in managing aggression in children and adolescents (2008) J Clin Psychiatry, 69 (SUPPL. 4), pp. 37-42Rutter, M., Taylor, E.A., (2002) Child and Adolescent Psychiatry, , Massachusets: Blackwell PublishmentConnor, D.F., Glatt, S.J., Lopez, I.D., Jackson, D., Melloni Jr., R.H., Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD (2002) J Am Acad Child Adolesc Psychiatry, 41, pp. 253-261Heyneman, E.K., The aggressive child (2003) Child Adolesc Psychiatr Clin N Am, 12, pp. 667-677Brasil, H.H., Belisário, F.J.F., Psicofarmacoterapia (2000) Rev Bras Psiquiatr, 22 (SUPLL. 2), pp. 42-47Olfson, M., Blanco, C., Liu, L., Moreno, C., Laje, G., National trends in the outpatient treatment of children and adolescents with antipsychotic drugs (2006) Arch Gen Psychiatry, 63, pp. 679-685Findling, R.L., Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents (2008) J Clin Psychiatry, 69 (SUPPL. 4), pp. 9-14Campbell, M., Armenteros, J.L., Malone, R.P., Adams, P.B., Eisenberg, Z.W., Overall, J.E., Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study (1997) J Am Acad Child Adolesc Psychiatry, 36, pp. 835-843Toren, P., Laor, N., Weizman, A., Use of atypical neuroleptics in child and adolescent psychiatry (1998) J Clin Psychiatry, 59, pp. 644-656Gilberg, C., Typical neuroleptics in chil and adolescent psychiatry (2000) Eur Child Adolesc Psychiatry, 9 (SUPPL. 1), pp. 2-8Consensus development conference on antipsychotic drugs and obesity and diabetes (2004) Diabetes Care, 27, pp. 596-601. , American Diabetes Association, American Association of Clinical Endocrinologists, North American Association for the Study of ObesityCorrell, C.U., Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes (2008) J Am Acad Child Adolesc Psychiatry, 47, pp. 9-20Correll, C.U., Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents (2008) J Clin Psychiatry, 69 (SUPPL. 4), pp. 26-36Correll, C.U., Penzner, J.B., Parikh, U.H., Mughal, T., Javed, T., Carbon, M., Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents (2006) Child Adolesc Psychiatr Clin N Am, 15, pp. 177-206Kumra, S., Frazier, J.A., Jacobsen, L.K., McKenna, K., Gordon, C.T., Lenane, M.C., Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison (1996) Arch Gen Psychiatry, 53, pp. 1090-1097Shaw, P., Sporn, A., Gogtay, N., Overman, G.P., Greenstein, D., Gochman, P., Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison (2006) Arch Gen Psychiatry, 63, pp. 721-730Wudarsky, M., Nicolson, R., Hamburger, S.D., Spechler, L., Gochman, P., Bedwell, J., Elevated prolactin in pediatric patients on typical and atypical antipsychotics (1999) J Child Adolesc Psychopharmacol, 9, pp. 239-245Aman, M.G., de Smedt, G., Derivan, A., Lyons, B., Findling, R.L., Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence (2002) Am J Psychiatry, 159, pp. 1337-1346Findling, R.L., McNamara, N.K., Branicky, L.A., Schluchter, M.D., Lemon, E., Blumer, J.L., A double-blind pilot study of risperidone in the treatment of conduct disorder (2000) J Am Acad Child Adolesc Psychiatry, 39, pp. 509-516Dunbar, F., Kusumakar, V., Daneman, D., Schulz, M., Growth and sexual maturation during long-term treatment with risperidone (2004) Am J Psychiatry, 161, pp. 918-920Lemmon, M.E., Gregas, M., Jeste, S.S., Risperidone use in autism spectrum disorders: A retrospective review of a clinic-referred patient population (2011) J Child Neurol, 26, pp. 428-432McDougle, C.J., Stigler, K.A., Erickson, C.A., Posey, D.J., Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders (2008) J Clin Psychiatry, 69 (SUPPL. 4), pp. 15-20McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M.G., Risperidone in children with autism and serious behavioral problems (2002) N Engl J Med, 347, pp. 314-321Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders (2004) Pediatrics, 114, pp. e634-e641Eberhard, J., Lindström, E., Holstad, M., Levander, S., Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders (2007) Acta Psychiatr Scand, 115, pp. 268-276Handen, B.L., Hardan, A.Y., Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavioral disorders (2006) J Am Acad Child Adolesc Psychiatry, 45, pp. 928-935Masi, G., Milone, A., Canepa, G., Millepiedi, S., Mucci, M., Muratori, F., Olanzapine treatment in adolescents with severe conduct disorder (2006) Eur Psychiatry, 21, pp. 51-57Potenza, M.N., Holmes, J.P., Kanes, S.J., McDougle, C.J., Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study (1999) J Clin Psychopharmacol, 19, pp. 37-44Malone, R.P., Cater, J., Sheikh, R.M., Choudhury, M.S., Delaney, M.A., Olanzapine versus haloperidol in children with autistic disorder: An open pilot study (2001) J Am Acad Child Adolesc Psychiatry, 40, pp. 887-894Daniel, D.G., Potkin, S.G., Reeves, K.R., Swift, R.H., Harrigan, E.P., Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: A double-blind, randomized trial (2001) Psychopharmacology (Berl), 155, pp. 128-134Meehan, K., Zhang, F., David, S., Tohen, M., Janicak, P., Small, J., A double-blind, randomized comparison of the effcacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania (2001) J Clin Psychopharmacol, 21, pp. 389-397Findling, R.L., Reed, M.D., O'Riordan, M.A., Demeter, C.A., Stansbrey, R.J., McNamara, N.K., Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder (2006) J Am Acad Child Adolesc Psychiatry, 45, pp. 792-800Findling, R.L., Reed, M.D., O'Riordan, M.A., Demeter, C.A., Stansbrey, R.J., McNamara, N.K., A 26-week open-label study of quetiapine in children with conduct disorder (2007) J Child Adolesc Psychopharmacol, 17, pp. 1-9Kronenberger, W.G., Giauque, A.L., Lafata, D.E., Bohnstedt, B.N., Maxey, L.E., Dunn, D.W., Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defant disorder, and aggression: A prospective, open-label study (2007) J Child Adolesc Psychopharmacol, 17, pp. 334-347Martin, A., Koenig, K., Scahill, L., Bregman, J., Open-label quetiapine in the treatment of children and adolescents with autistic disorder (1999) J Child Adolesc Psychopharmacol, 9, pp. 99-107Findling, R.L., McNamara, N.K., Gracious, B.L., O'Riordan, M.A., Reed, M.D., Demeter, C., Quetiapine in nine youths with autistic disorder (2004) J Child Adolesc Psychopharmacol, 14, pp. 287-294McDougle, C.J., Kem, D.L., Posey, D.J., Case series: Use of ziprasidone for maladaptive symptoms in youths with autism (2002) J Am Acad Child Adolesc Psychiatry, 41, pp. 921-927Stigler, K.A., Posey, D.J., McDougle, C.J., Aripiprazole for maladaptive behavior in pervasive developmental disorders (2004) J Child Adolesc Psychopharmacol, 14, pp. 455-463Valicenti-McDermott, M.R., Demb, H., Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities (2006) J Child Adolesc Psychopharmacol, 16, pp. 549-560Kranzler, H., Roofeh, D., Gerbino-Rosen, G., Dombrowski, C., McMeniman, M., Dethomas, C., Clozapine: Its impact on aggressive behavior among children and adolescents with schizophrenia (2005) J Am Acad Child Adolesc Psychiatry, 44, pp. 55-63Zuddas, A., Ledda, M.G., Fratta, A., Muglia, P., Cianchetti, C., Clinical effects of clozapine on autistic disorder (1996) Am J Psychiatry, 153, p. 738Chen, N.C., Bedair, H.S., McKay, B., Bowers Jr., M.B., Mazure, C., Clozapine in the treatment of aggression in an adolescent with autistic disorder (2001) J Clin Psychiatry, 62, pp. 479-480Gogtay, N., Rapoport, J., Clozapine use in children and adolescents (2008) Expert Opin Pharmacother, 9, pp. 459-465Gerbino-Rosen, G., Roofeh, D., Tompkins, D.A., Feryo, D., Nusser, L., Kranzler, H., Hematological adverse events in clozapine-treated children and adolescents (2005) J Am Acad Child Adolesc Psychiatry, 44, pp. 1024-1031Pappadopulos, E.A., Siennick, S.E., Jensen, P.S., Antipsychotics for aggressive adolescents: Barriers to best practice (2003) Expert Rev Neurother, 3, pp. 85-98Findling, R.L., Frazier, J.A., Gerbino-Rosen, G., Kranzler, H.N., Kumra, S., Kratochvil, C.J., Is there a role for clozapine in the treatment of children and adolescents? (2007) J Am Acad Child Adolesc Psychiatry, 46, pp. 423-428Gobbi, G., Pulvirenti, L., Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour (2001) J Psychiatry Neurosci, 26, pp. 340-341Kraus, J.E., Sheitman, B.B., Clozapine reduces violent behavior in heterogeneous diagnostic groups (2005) J Neuropsychiatry Clin Neurosci, 17, pp. 36-44Smith, H., White, T., The effect of clozapine on the social behaviour schedule in patients attending a forensic psychiatry day hospital (2004) Med Sci Law, 44, pp. 213-216Sikich, L., Effcacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders (2008) J Clin Psychiatry, 69 (SUPPL. 4), pp. 21-25Correll, C.U., Metabolic side effects of second-generation antipsychotics in children and adolescents: A different story? (2005) J Clin Psychiatry, 66, pp. 1331-1332Stigler, K.A., McDougle, C.J., Pharmacotherapy of irritability in pervasive developmental disorders (2008) Child Adolesc Psychiatr Clin N Am, 17, pp. 739-752